Saturday 17 October 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024. In the quarter to June 2026, revenue grew 21.6%, EPS grew 112.0%, free cash flow fell 153.7% and total debt rose 70.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.
64.72
6.41
−9.01%
Follow TEM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
12.78 | 8.09 | 5.93 | 7.28 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(117.82) | (279.72) | (110.39) | (1,385.06) | |
P/B ratio |
27.80 | 20.94 | 19.43 | 23.43 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
13.21 | 8.47 | 6.37 | 7.66 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(66.22) | (49.41) | (46.75) | (46.19) | |
EV/FCF |
(58.55) | (43.92) | (39.52) | (40.18) | |
Quick Ratio |
2.98 | 2.86 | 2.98 | 3.01 | |
Current Ratio |
3.28 | 3.13 | 3.31 | 3.30 | |
Net Debt/EBITDA |
(14.98) | (14.71) | (10.42) | (11.31) | |
Debt/Assets |
54.60% | 54.49% | 57.76% | 57.51% | |
Debt/Equity |
2.45 | 2.52 | 2.96 | 3.06 | |
Asset Turnover |
0.68 | 0.79 | 0.74 | 0.72 | |
Operating CF/Net income |
1.50 | 0.68 | 0.58 | (1.33) | |
Capex/Depreciation |
(0.28) | (0.22) | (0.36) | (0.40) | |
Interest Coverage |
(3.96) | (4.02) | (5.91) | (7.38) | |
Research and Development Expense of Revenue |
24.85% | 24.68% | 27.05% | 25.25% | |
Selling, General and Administrative Expense of Revenue |
56.22% | 56.78% | 61.07% | 59.05% | |
Intangible Assets out of Total Assets |
0.37 | 0.36 | 0.38 | 0.33 | |
Share Based Compensation of Revenue |
10.17% | 12.35% | 15.14% | 14.15% | |
Graham Net Nets |
(0.04) | (0.06) | (0.08) | (0.06) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1.47%) | (2.39%) | (3.78%) | (2.47%) | |
Free Cash Flow Yield |
(1.77%) | (2.38%) | (2.72%) | (2.62%) | |
Revenue per Share |
1.91 | 2.11 | 1.95 | 2.13 | |
Operating CF per Share |
(0.68) | (0.21) | (0.41) | (0.04) | |
Capex per Share |
(0.05) | (0.04) | (0.06) | (0.06) | |
Free Cash Flow per Share |
(0.73) | (0.25) | (0.47) | (0.10) | |
Cash per Share |
4.34 | 4.33 | 3.57 | 4.54 | |
Shareholders Equity per Share |
2.90 | 2.82 | 2.33 | 2.47 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.90 | 2.82 | 2.33 | 2.47 | |
Free Cash Flow |
(127.89) | (43.12) | (83.34) | (18.62) | |
Working Capital |
796.48 | 794.79 | 735.99 | 899.37 | |
Capital Expenditures |
(8.05) | (6.34) | (10.07) | (11.09) | |
Net Current Asset Value |
(627.09) | (616.34) | (664.74) | (630.11) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
214.62 | 232.99 | 285.61 | 313.60 | |
Average Payables |
54.29 | 67.90 | 64.88 | 76.57 | |
Average Inventory |
45.56 | 45.06 | 51.16 | 50.56 | |
Average Assets |
1,626.58 | 1,600.48 | 1,839.11 | 1,995.64 | |
Average Common Equity |
280.78 | 273.83 | 371.30 | 377.25 |
Columns are period end dates